Gesine Meyer-Rath

Summary

Affiliation: Boston University
Country: USA

Publications

  1. pmc Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
    Fern Terris-Prestholt
    London School of Hygiene and Tropical Medicine, London, UK
    BMC Infect Dis 14:14. 2014
  2. pmc Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa
    Gesine Meyer-Rath
    Center for Global Health and Development, Boston University, Boston, MA, USA
    J Acquir Immune Defic Syndr 62:322-328. 2013
  3. ncbi request reprint Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa
    Gesine Meyer-Rath
    Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Acquir Immune Defic Syndr 61:e25-32. 2012
  4. pmc The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
    Gesine Meyer-Rath
    Health Economics and Epidemiology Research Office HE2RO, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 7:e36966. 2012
  5. pmc HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions
    Gesine Meyer-Rath
    Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America
    PLoS Med 9:e1001247. 2012
  6. pmc Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
    Kathryn Schnippel
    Health Economics and Epidemiology Research Office, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
    Trop Med Int Health 17:1142-51. 2012
  7. ncbi request reprint Cost and outcomes of paediatric antiretroviral treatment in South Africa
    Gesine Meyer-Rath
    Center for Global Health and Development, Boston University, Boston, Massachusetts 02118, USA
    AIDS 27:243-50. 2013
  8. ncbi request reprint Attrition through multiple stages of pre-treatment and ART HIV care in South Africa
    Matthew P Fox
    Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 9:e110252. 2014
  9. pmc Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis
    Callie A Scott
    Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America
    PLoS ONE 8:e67910. 2013
  10. pmc Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study
    Katharina Kranzer
    Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom
    PLoS Med 9:e1001281. 2012

Collaborators

Detail Information

Publications10

  1. pmc Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
    Fern Terris-Prestholt
    London School of Hygiene and Tropical Medicine, London, UK
    BMC Infect Dis 14:14. 2014
    ....
  2. pmc Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa
    Gesine Meyer-Rath
    Center for Global Health and Development, Boston University, Boston, MA, USA
    J Acquir Immune Defic Syndr 62:322-328. 2013
    ..Raising ART eligibility thresholds could avoid the high cost of hospitalization before and immediately after ART initiation...
  3. ncbi request reprint Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa
    Gesine Meyer-Rath
    Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Acquir Immune Defic Syndr 61:e25-32. 2012
    ..South Africa has the world's largest number of patients on antiretroviral treatment (ART). As coverage expands beyond urban environments, the cost of care is becoming increasingly important...
  4. pmc The impact and cost of scaling up GeneXpert MTB/RIF in South Africa
    Gesine Meyer-Rath
    Health Economics and Epidemiology Research Office HE2RO, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 7:e36966. 2012
    ....
  5. pmc HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions
    Gesine Meyer-Rath
    Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America
    PLoS Med 9:e1001247. 2012
    ..Adjusting previously estimated costs of universal testing and treatment in South Africa for diseconomies of small scale, i.e., more patients being treated in smaller facilities, adds 42% to the expected future cost of the intervention...
  6. pmc Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
    Kathryn Schnippel
    Health Economics and Epidemiology Research Office, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
    Trop Med Int Health 17:1142-51. 2012
    ..We used recent South African data to compare the cost of placing Xpert at points of TB treatment (all primary clinics and hospitals) with the cost of placement at sub-district laboratories...
  7. ncbi request reprint Cost and outcomes of paediatric antiretroviral treatment in South Africa
    Gesine Meyer-Rath
    Center for Global Health and Development, Boston University, Boston, Massachusetts 02118, USA
    AIDS 27:243-50. 2013
    ..We analysed the average cost of providing paediatric ART in South Africa during the first 2 years after ART initiation, stratified by patient outcomes...
  8. ncbi request reprint Attrition through multiple stages of pre-treatment and ART HIV care in South Africa
    Matthew P Fox
    Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 9:e110252. 2014
    ..While estimates of retention on ART exist, few cohorts have data on retention from testing positive through long-term ART care...
  9. pmc Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis
    Callie A Scott
    Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America
    PLoS ONE 8:e67910. 2013
    ....
  10. pmc Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study
    Katharina Kranzer
    Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom
    PLoS Med 9:e1001281. 2012
    ..This study aimed to assess feasibility, uptake, yield, treatment outcomes, and costs of adding an active tuberculosis case-finding program to an existing mobile HIV testing service...